abstract |
The present invention relates to a novel tricyclic compound. The present invention provides compounds of formula (I) and formula (II), pharmaceutically acceptable salts, prodrugs, biologically active metabolites, stereoisomers and isomers thereof, where variables are defined here. The compounds of the present invention are useful in the treatment of immune and tumor diseases. |